SanBio Co

SanBio Co Stock-Based Compensation

The Stock-Based Compensation (SBC) of SanBio Co (4592.T) as of Nov 6, 2026 is 72.65 M JPY. In the previous year, Stock-Based Compensation (SBC) was 19,238.00 JPY — a change of 377,538.01% (higher).

Stock-Based Compensation

72.65 MJPY

YoY

377,538.01%

Last updated:

Stock-Based Compensation (SBC) of SanBio Co is 2026 72.65 M JPY. Stock-Based Compensation (SBC) of SanBio Co was 2025 19,238.00 JPY. It decreases by 377,538.01% higher compared to the previous year.

The SanBio Co Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
27.92 M JPY
Jan 1, 2020
70.94 M JPY
Jan 1, 2021
112.47 M JPY
Jan 1, 2022
141.24 M JPY
Jan 1, 2023
102.98 M JPY
Jan 1, 2024
34.18 M JPY
Jan 1, 2025
19,238.00 JPY
Jan 1, 2026
72.65 M JPY
The SanBio Co Stock-Based Compensation history
YEARStock-Based CompensationYoY
72.65 MJPY+377,538.01%
19,238.00JPY-99.94%
34.18 MJPY-66.81%
102.98 MJPY-27.09%
141.24 MJPY+25.58%
112.47 MJPY+58.53%
70.94 MJPY+154.08%
27.92 MJPY+120.76%
12.65 MJPY-15.98%
15.05 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

Stock-Based Compensation (SBC) of SanBio Co is 72.65 M JPY in 2026.

Stock-Based Compensation (SBC) of SanBio Co changed from 19,238.00 JPY to 72.65 M JPY, representing a 377,538.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) SanBio Co since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s SanBio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — SanBio Co

All Key Metrics — SanBio Co